Evidence map›Paper›PMID 37855410›Full record

ArticleEuropean thyroid journal2023

Hypothyroid women have persistently higher oxidative stress compared to healthy controls.

Kamilla R Riis, Camilla B Larsen, Bjarke R Medici, Christian Z Jensen, Kristian H Winther, Emil L Larsen, Christina Ellervik, Jeppe L la Cour, Laszlo Hegedüs, Thomas H Brix and 4 more

Open access · diamondAbstract read
In one paragraph

Article in European thyroid journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. THRA1/PGC-1α/SIRT3 pathway regulates oxidative stress and is implicated in hypertension of maternal hypothyroid rat offspring.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Kamilla R RiisDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-2679-7153
Camilla B LarsenDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-7342-8660
Bjarke R MediciDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.ORCID 0000-0000-0000-0000
Christian Z JensenDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.ORCID 0000-0002-5882-2547
Kristian H WintherDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0001-5210-4029
Emil L LarsenDepartment of Clinical Pharmacology, Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark.ORCID 0000-0002-0676-0858
Christina EllervikDepartment of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, United States of America.ORCID 0000-0002-3088-4375
Jeppe L la CourDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.ORCID 0000-0001-6351-9430
Laszlo HegedüsDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-9691-7619
Thomas H BrixDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-2327-531x
Henrik E PoulsenDepartment of Endocrinology, Copenhagen University Hospital, Bispebjerg-Frederiksberg Hospital, Denmark.ORCID 0000-0003-4242-9924
Filip K KnopDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.ORCID 0000-0002-2495-5034
Birte NygaardDepartment of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Denmark.ORCID 0000-0002-9540-4950
Steen J BonnemaDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.ORCID 0000-0002-6898-1752
Odense University Hospital · DKUniversity of Copenhagen · DKGentofte Hospital · DKHerlev Hospital · DKFrederiksberg Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Some studies suggest that hypothyroidism is associated with increased oxidative stress. Urinary excretion of 8-oxo-7,8-dihydroguanosine (8-oxoGuo) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) represents whole-body RNA and DNA oxidation, respectively. These biomarkers have only been explored sparsely in patients with thyroid disorders. Methods: In 45 Danish women with newly diagnosed hypothyroidism, we compared 8-oxoGuo and 8-oxodG before or shortly after initiating levothyroxine with the excretion rates at euthyroidism. We also compared the excretion of 8-oxoGuo and 8-oxodG in the patients after restored euthyroidism with 18 healthy control subjects. Results: Compared with baseline, none of the biomarkers changed significantly in the patients after becoming euthyroid. The geometric mean of 8-oxoGuo was 1.63 (95% CI: 1.49-1.78) nmol/mmol creatinine at baseline and 1.67 nmol/mmol at euthyroidism (95% CI: 1.53-1.83) (P = 0.39), while that of 8-oxodG was 1.28 nmol/mmol creatinine at baseline (95% CI: 1.14-1.44) and 1.32 nmol/mmol at euthyroidism (95% CI: 1.18-1.48), respectively (P = 0.47). The relative mean differences were 0.97 (95% CI: 0.91-1.04) for 8-oxoGuo and 0.97 (95% CI: 0.88-1.06) for 8-oxodG. At baseline, multiple linear regression revealed a positive association between free thyroxine and both biomarkers (8-oxoGuo, P < 0.001; 8-oxodG, P = 0.04). Furthermore, 8-oxoGuo was positively associated with age (P = 0.04) and negatively associated with thyrotropin (P = 0.02). In the control group, the geometric mean of 8-oxoGuo was 1.23 nmol/mmol creatinine (95% CI: 1.07-1.42), while that of 8-oxodG was 1.04 nmol/mmol creatinine (95% CI: 0.88-1.23). Thus, compared with control subjects, euthyroid patients showed a significantly higher level of both 8-oxoGuo (P < 0.001) and 8-oxodG (P = 0.03). Conclusion: In hypothyroid women, no significant effect of levothyroxine treatment on the oxidative stress biomarkers 8-oxoGuo and 8-oxodG could be demonstrated. However, the excretion of these biomarkers was significantly higher than in healthy controls.

Indexed as

HypothyroidismThyroxine8-Hydroxy-2'-DeoxyguanosineBiomarkersCreatinineFemaleHumansOxidative Stress8-Hydroxy-2'-DeoxyguanosineBiomarkersCreatinineThyroxine8-oxo-7,8-dihydro-2′-deoxyguanosine8-oxo-7,8-dihydroguanosine8-oxodG8-oxoGuohypothyroidismoxidative stress

Identifiers

PMID37855410
PMCPMC10692686
OpenAlexW4387524760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.